Skip to main content

RxNews®

Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.

Jesduvroq® (daprodustat) – Withdrawal from the market

December 19, 2024 - GSK announced the decision to voluntarily withdraw Jesduvroq (daprodustat) from the US marketplace due to business reasons. The withdrawal is not due to any safety or efficacy issues.  

Download PDF